Janney Montgomery Scott analyst Robert Stevenson downgrades Gladstone Commercial (NASDAQ:GOOD) from Buy to Neutral.
Jasper Therapeutics Announces Appointment Of Thomas G. Wiggans As Chairperson Of The Board Of Directors
Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a biotechnology company focused on the development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic